Serena Williams is championing GLP-1 drugs for weight loss after having trouble shedding pounds following the birth of her ...

C-store retailers answer this Rovertown ‘hot, or not’ question as well others on GLP-1, Gen Zers and more at Outlook Leadership ...

Dr. Sterling Elliott, Clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School ...

Serena Williams sat down with the hosts of Today for a candid interview about her use of GLP-1 medication. The Olympic ...

GLP-1 meds are trending after Serena Williams’ 31-pound weight loss. A doctor breaks down the side effects, safety concerns & ...

Serena Williams may not be playing in the 2025 US Open, but she still knows how to serve in activewear.

Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers. The cohort study was led by researchers from the Indiana ...

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions ...

Serena Williams has announced to the world loud and proud that she's been taking GLP-1 medication in a bid to lose 31 pounds.

Medications like Ozempic mimic the GLP-1 hormone, so the user feels fuller for longer and doesn’t crave food as often.

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...